Sevoflurane, Propofol and Desflurane on POD/POCD

Sponsor
Shanghai 10th People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03326960
Collaborator
Massachusetts General Hospital (Other)
300
1
65.9
4.5

Study Details

Study Description

Brief Summary

The investigators will perform clinical studies to test the hypothesis that participants who have total hip/knee replacement under sevoflurane, propofol or desflurane anesthesia will have different effects on the incidence and severity of POD/POCD, and POD/POCD is associated with retinal nerve fiber layer (RNFL) thickness, as well as Serum level of vitamin B12, folic acid, homocysteine and human myeloid differentiation protein-2 (MD-2s). The investigators plan to perform the studies in 300 participants at Shanghai 10th People's Hospital.

Condition or Disease Intervention/Treatment Phase

Detailed Description

Postoperative delirium (POD) and postoperative cognitive disorder (POCD) are the most common complications of geriatric surgical patients, which could cause long-term social dysfunction, high mortality and increased medical cost. Currently, there is no efficient biomarker for POD/POCD, and it also remains largely unknown whether different anesthesia might lead to different incidence and severity of POD/POCD. The investigator's previous studies showed that thickness of retinal nerve fiber layer thickness (RNFL-T) measured by optical coherence tomography (OCT) was associated with POD/POCD; change of RNFL thickness (RNFL-C) in certain period correlated with cognitive deterioration. Thus, the investigators consider that RNFL might be a potential biomarker of POD/POCD. In the proposed large-scale longitudinal studies, the investigators will clinically validate RNF-LT as pre-operative POD/POCD biomarker, and RNFL-C as post-operative biomarker of POD/POCD. Finally, the investigators will compare the effects of surgery (total hip/knee replacement) under general anesthesia with sevoflurane, propofol and desflurane on the incidence and severity of POD/POCD in patients. Results from the proposed studies will likely establish RNFL as a potential POD/POCD biomarker, promote the clinical utilization of OCT-RNFL in early screening and outcome prediction of POD/POCD, and finally optimize anesthesia care of geriatric surgical patients to avoid or reduce POD/POCD incidence. These findings will lead to better postoperative outcomes of geriatric patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effects of Anesthetics Sevoflurane, Propofol and Desflurane on Postoperative Delirium (POD) and Postoperative Cognitive Disorder (POCD)
Actual Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Sevoflurane

Patients in Sevoflurane group are maintained with sevoflurane from an anesthesia machine through the laryngeal mask airway guided by Narcrotrend index monitoring.

Drug: Sevoflurane
Anesthesia maintenance with sevoflurane guided by Narcrotrend index monitoring.

Propofol

Patients in Propofol group are maintained with propofol through intravenous administration guided by Narcrotrend index monitoring.

Drug: Propofol
Anesthesia maintenance with propofol guided by Narcrotrend index monitoring.

Desflurane

Patients in Desflurane group are maintained with desflurane from an anesthesia machine through the laryngeal mask airway guided by Narcrotrend index monitoring.

Drug: Desflurane
Anesthesia maintenance with desflurane guided by Narcrotrend index monitoring.

Outcome Measures

Primary Outcome Measures

  1. Postoperative delirium [At 1st day after the surgery]

    Postoperative delirium will be determined by Confusion Assessment Method (CAM) at 1st postoperative day

Secondary Outcome Measures

  1. Postoperative delirium [At 2nd day after the surgery]

    Postoperative delirium will be determined by CAM at 2nd postoperative day

  2. Postoperative delirium [At 3rd day after the surgery]

    Postoperative delirium will be determined by CAM at 3rd postoperative day

  3. Preoperative cognitive function [Preoperative cognitive function (baseline)]

    Preoperative cognitive function will be assessed by neuropsychological battery

  4. Postoperative cognitive dysfunction [Change from baseline cognitive dysfunction at 1 week]

    Postoperative cognitive dysfunction will be assessed by neuropsychological battery before and after the surgery and anesthesia

  5. Postoperative cognitive dysfunction [Change from baseline cognitive dysfunction at 3rd month]

    Postoperative cognitive dysfunction will be assessed by neuropsychological battery

  6. Retinal nerve fiber layer thickness [Change from baseline RNFL thickness at 3rd month]

    Retinal nerve fiberlayer(RNFL)thickness will be measured by optical coherence tomography (OCT) before and after surgery and anesthesia

  7. Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) [Before the surgery (baseline)]

    vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested

  8. Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) [At 1st day after the surgery]

    vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested

  9. Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) [At 2nd day after the surgery]

    vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested

  10. Serum level of vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) [At 3rd day after the surgery]

    vitamin B12, folic acid, homocysteine and myeloid differentiation protein-2 (MD-2s) will be tested

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 60 years old or older

  • Chinese Mandarin as the native language

  • scheduled to undergo hip/knee surgery under general anesthesia

  • American Society of Anesthesiologists (ASA) class I-Ⅲ

Exclusion Criteria:
  • Prior diagnoses of neurological diseases according to ICD-10

  • History of severe psychiatric disorders according to DSM-IV

  • Visual or auditory defects

  • Participating in the investigation of another study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai 10th People's Hospital Shanghai Shanghai China 200072

Sponsors and Collaborators

  • Shanghai 10th People's Hospital
  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Yuan Shen, M.D.,Ph.D, Shanghai 10th People's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yuan Shen, MD, PhD, Head of Psychiatry, Shanghai 10th People's Hospital
ClinicalTrials.gov Identifier:
NCT03326960
Other Study ID Numbers:
  • dsyy002
First Posted:
Oct 31, 2017
Last Update Posted:
Oct 22, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yuan Shen, MD, PhD, Head of Psychiatry, Shanghai 10th People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2020